Core Viewpoint - The company aims to seize opportunities for growth, actively expand its market presence, and enhance its competitive advantages while striving to provide high-quality services to customers [2] Group 1 - The company is focused on developing and expanding its market [2] - The company emphasizes strengthening its competitive advantages [2] - The company is committed to delivering quality services to its clients [2]

Core Viewpoint - The company, Nossger (301333), aims to enhance management efficiency and strengthen competitive advantages to provide high-quality services to customers [1] Group 1 - The company will base its strategies on its own development plans [1] - The focus will be on improving management efficiency [1] - The company is committed to maximizing efforts in delivering quality services to clients [1]

（文章来源：证券日报） 证券日报网讯博济医药7月29日在互动平台回答投资者提问时表示，截至2024年度，公司累计与900余家 临床试验服务机构开展合作，大部分三甲医院均有合作过。 ...

泰格医药（300347）公告，全资附属公司株式会社泰格医药日本与日本MICRON原股东签署《股份转让 协议》，购买其持有的部分MICRON股权，本次转让完成后，日本泰格将持有MICRON56.37%股权。 MICRON成立于2005年，总部位于日本东京，员工人数超过160人，是一家专注于医学影像及临床试验 服务的CRO公司。MICRON截至2025年5月31日总资产7.81亿日元，净资产-4.52亿日元；2025年1-5月主 营业务收入9.4亿日元，净利润-6704.74万日元。 ...